Saturday, July 11, 2026

pharma · Hypertriglyceridemia

Mochida Pharmaceutical

Mochida Pharmaceutical Company is a pharma organization headquartered in CN. Primary therapeutic focus areas include Hypertriglyceridemia. NovaPharmaNews links 3 clinical program(s), 0 drug profile(s), and 0 patent recor

USA HQ
42 Employees
NMPA registrant Type
Company details
Status
Public
HQ
USA
Employees
42
Programs
3
Drugs
2
Patents
0
Clinical program

FYU-981

Phase 1 · small molecule · Healthy

FYU-981 for Healthy is a Phase 1 program (small_molecule) at Mochida Pharmaceutical Company, with 1 ClinicalTrials.gov record(s).

Internal code FYU-981-016

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Mochida Pharmaceutical Company,
Phase
Phase 1
Modality
small_molecule
Indication
Healthy
Status
completed
Trials
1

Clinical trials